{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:31:33Z","timestamp":1792783893059,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI130025"],"award-info":[{"award-number":["R01 AI130025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR069071"],"award-info":[{"award-number":["AR069071"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taubman Medical Research Institute Frances and Kenneth Eisenberg Emerging Scholar Award (JEG)"},{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation (MKS, LCT)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000964","name":"Arthritis National Research Foundation (LCT)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001582","name":"Dermatology Foundation (LCT)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Dermatology Babcock Endowment Fund"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.coi.2017.07.007","type":"journal-article","created":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T15:47:13Z","timestamp":1500738433000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":222,"special_numbering":"C","title":["Psoriasis: a mixed autoimmune and autoinflammatory disease"],"prefix":"10.1016","volume":"49","author":[{"given":"Yun","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal K","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lam C","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann E","family":"Gudjonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2017.07.007_bib0235","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.1980.tb05690.x","article-title":"Psoriasis and HLA-Cw6","volume":"102","author":"Tiilikainen","year":"1980","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2017.07.007_bib0240","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1086\/503821","article-title":"Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene","volume":"78","author":"Nair","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.coi.2017.07.007_bib0245","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0190-9622(85)70188-0","article-title":"Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris","volume":"13","author":"Henseler","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2017.07.007_bib0250","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1046\/j.1365-2133.2000.03885.x","article-title":"HLA-C and guttate psoriasis","volume":"143","author":"Mallon","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2017.07.007_bib0255","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","article-title":"A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2017.07.007_bib0260","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2017.07.007_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2004.02310.x","article-title":"Immunopathogenic mechanisms in psoriasis","volume":"135","author":"Gudjonsson","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2017.07.007_bib0270","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.4049\/jimmunol.1302313","article-title":"Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis","volume":"192","author":"Cheuk","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2017.07.007_bib0275","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1046\/j.0022-202x.2001.01548.x","article-title":"Oligoclonal expansion of intraepidermal T cells in psoriasis skin lesions","volume":"117","author":"Lin","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2017.07.007_bib0280","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1038\/jid.2012.163","article-title":"Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial","volume":"132","author":"Papp","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2017.07.007_bib0285","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis\u2014results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2017.07.007_bib0290","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaci.2015.10.046","article-title":"Targeting CD8(+) T cells prevents psoriasis development","volume":"138","author":"Di Meglio","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.07.007_bib0295","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nm1605","article-title":"Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis","volume":"13","author":"Conrad","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2017.07.007_bib0300","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2249.1999.01013.x","article-title":"Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis?","volume":"117","author":"Gudmundsdottir","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2017.07.007_bib0305","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2249.2004.00600.x","article-title":"Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells","volume":"138","author":"Johnston","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2017.07.007_bib0310","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2017.07.007_sbref0315","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1084\/jem.20151093","article-title":"Melanocyte antigen triggers autoimmunity in human psoriasis","volume":"212","author":"Arakawa","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2017.07.007_bib0320","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1038\/jid.2011.222","article-title":"IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms","volume":"131","author":"Shi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2017.07.007_bib0325","doi-asserted-by":"crossref","DOI":"10.1111\/exd.13378","article-title":"Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active psoriasis and localized with keratinocytes, dendritic cells and other leukocytes","author":"Fuentes-Duculan","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.coi.2017.07.007_sbref0330","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1172\/JCI92217","article-title":"CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice","volume":"127","author":"Bagchi","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2017.07.007_sbref0335","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1084\/jem.20160258","article-title":"Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a","volume":"213","author":"Cheung","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2017.07.007_bib0340","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1084\/jem.20141904","article-title":"The role of group IIF-secreted phospholipase A2 in epidermal homeostasis and hyperplasia","volume":"212","author":"Yamamoto","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2017.07.007_bib0345","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/wsbm.32","article-title":"Role of neutrophils in innate immunity: a systems biology-level approach","volume":"1","author":"Kobayashi","year":"2009","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"10.1016\/j.coi.2017.07.007_sbref0350","article-title":"IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis","author":"Johnston","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.07.007_bib0355","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2017.07.007_bib0360","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2017.07.007_bib0365","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1471-4906(01)02034-8","article-title":"Annotating genes with potential roles in the immune system: six new members of the IL-1 family","volume":"22","author":"Dunn","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2017.07.007_bib0370","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.4049\/jimmunol.1003162","article-title":"IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression","volume":"186","author":"Johnston","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2017.07.007_bib0375","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","article-title":"IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin","volume":"192","author":"Foster","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2017.07.007_bib0380","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","article-title":"Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis","volume":"89","author":"Onoufriadis","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.coi.2017.07.007_bib0385","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2017.07.007_bib0390","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2017.07.007_bib0395","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/jid.2012.490","article-title":"Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes","volume":"133","author":"Setta-Kaffetzi","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2017.07.007_bib0400","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/jid.2013.285","article-title":"Loss of IL36RN function does not confer susceptibility to psoriasis vulgaris","volume":"134","author":"Berki","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2017.07.007_bib0405","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ajhg.2014.04.005","article-title":"AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking","volume":"94","author":"Setta-Kaffetzi","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.coi.2017.07.007_bib0410","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ajhg.2012.03.013","article-title":"Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis","volume":"90","author":"Jordan","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.coi.2017.07.007_bib0415","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","article-title":"PSORS2 is due to mutations in CARD14","volume":"90","author":"Jordan","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.coi.2017.07.007_bib0420","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/j.1460-2075.1990.tb08268.x","article-title":"A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence","volume":"9","author":"Rubartelli","year":"1990","journal-title":"EMBO J"},{"key":"10.1016\/j.coi.2017.07.007_bib0425","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/315641a0","article-title":"Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs","volume":"315","author":"March","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.coi.2017.07.007_sbref0430","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.celrep.2015.12.072","article-title":"Neutrophil-derived proteases escalate inflammation through activation of IL-36 family cytokines","volume":"14","author":"Henry","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2017.07.007_bib0435","doi-asserted-by":"crossref","first-page":"42594","DOI":"10.1074\/jbc.M111.267922","article-title":"Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta, and IL-36gamma) or antagonist (IL-36Ra) activity","volume":"286","author":"Towne","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2017.07.007_bib0440","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/febs.14075","article-title":"Neutrophil extracellular traps can serve as platforms for processing and activation of IL-1 family cytokines","volume":"284","author":"Clancy","year":"2017","journal-title":"FEBS J"},{"key":"10.1016\/j.coi.2017.07.007_sbref0445","doi-asserted-by":"crossref","first-page":"E2748","DOI":"10.1073\/pnas.1620954114","article-title":"Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36gamma","volume":"114","author":"Ainscough","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2017.07.007_bib0450","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10067-010-1504-5","article-title":"An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)","volume":"29","author":"Jung","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.coi.2017.07.007_bib0455","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7326\/0003-4819-153-1-201007060-00030","article-title":"Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist Anakinra: lack of correlation with IL1RN mutations","volume":"153","author":"Viguier","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.coi.2017.07.007_bib0460","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bjd.14685","article-title":"Successful response in a case of severe pustular psoriasis after interleukin-1beta inhibition","volume":"176","author":"Skendros","year":"2017","journal-title":"Br J Dermatol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791517300444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791517300444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:43:13Z","timestamp":1760604193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791517300444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":46,"alternative-id":["S0952791517300444"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2017.07.007","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis: a mixed autoimmune and autoinflammatory disease","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2017.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}